<DOC>
	<DOCNO>NCT00969254</DOCNO>
	<brief_summary>Clinical Study , prospective , comparative , randomize , double-dummy entry random total 80 patient , 40 patient receive test medication ( Pílulas de Lussen® ) plus placebo 40 patient receive comparative ( Pyridium® ) plus placebo .</brief_summary>
	<brief_title>Study Assess Efficacy Safety `` Pílulas de Lussen® '' Compared Pyridium® Symptomatic Control Dysuria</brief_title>
	<detailed_description>Phase III Clinical Study , prospective , multicenter , double-blind , randomize , double-dummy ass efficacy safety `` Pílulas de Lussen® '' compare Pyridium® symptomatic control dysuria 80 patient either sex race , old 18 year , symptom dysuria , 40 patient receive test medication ( Pílulas de Lussen® ) plus placebo 40 patient receive comparative ( Pyridium® ) plus placebo evaluate effectiveness tolerability 'Pílulas de Lussen ' symptomatic relief dysuria .</detailed_description>
	<mesh_term>Dysuria</mesh_term>
	<criteria>Patients age 18 year ; Patients symptom dysuria characterize pain/burning sensation low urinary tract discomfort urination ; Patients female childbearing age use reliable method contraception negative pregnancy test . Patients consent participate study . Patients sensitivity component formula ; Patients pregnant lactating ; Patients history glaucoma , heart failure , cardiac arrhythmia , prostatic hypertrophy , paralytic ileus pyloric stenosis ; Patients menorrhagia heavy menstrual period ; Patients need use antibiotic chemotherapy ; Patients follow procedure show Clinical Protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Pílulas de Lussen</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Dysuria</keyword>
	<keyword>Symptomatic control</keyword>
</DOC>